Safety and Tolerability of Besifloxacin Ophthalmic Suspension 0.6% in the Treatment of Bacterial Conjunctivitis: Data from Six Clinical and Phase I Safety Studies

By Comstock Timothy L.  

Clinical Drug Investigation, Vol. 30, Iss. 10, 2010-10 ,pp. : 675-685

Adis International

Access to resources Recommend Favorite

Besifloxacin Ophthalmic Suspension 0.6%

By Carter Natalie J.   Scott Lesley J.  

Drugs, Vol. 70, Iss. 1, 2010-01 ,pp. : 83-97

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Besifloxacin Ophthalmic Suspension 0.6% in Children and Adolescents with Bacterial Conjunctivitis: A Post Hoc, Subgroup Analysis of Three Randomized, Double-Masked, Parallel-Group, Multicenter Clinical Trials

By Comstock Timothy L.  

Pediatric Drugs, Vol. 12, Iss. 2, 2010-04 ,pp. : 105-112

Adis International

Access to resources Recommend Favorite

Moxifloxacin 0.5% Ophthalmic Solution: In Bacterial Conjunctivitis

By Keating Gillian M.  

Drugs, Vol. 71, Iss. 1, 2011-01 ,pp. : 89-99

Adis International

Access to resources Recommend Favorite

Oral Telithromycin 800 mg Once Daily for 5 Days versus Cefuroxime Axetil 500 mg Twice Daily for 10 Days in Adults with Acute Exacerbations of Chronic Bronchitis

By Zervos MJ   Heyder AM   Leroy B  

The Journal of International Medical Research, Vol. 31, Iss. 3, 2003-05 ,pp. : 157-169

Field House Publishing

Access to resources Recommend Favorite